Sipuleucel-T (Provenge(®))-Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention.
about
Sipuleucel-T (Provenge(®))-Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Sipuleucel-T (Provenge(®))-Aut ...... on its Breakthrough Invention.
@en
Sipuleucel-T
@nl
type
label
Sipuleucel-T (Provenge(®))-Aut ...... on its Breakthrough Invention.
@en
Sipuleucel-T
@nl
prefLabel
Sipuleucel-T (Provenge(®))-Aut ...... on its Breakthrough Invention.
@en
Sipuleucel-T
@nl
P2860
P1433
P1476
Sipuleucel-T (Provenge(®))-Aut ...... on its Breakthrough Invention.
@en
P2093
Mondher Toumi
Szymon Jarosławski
P2860
P2888
P304
P356
10.1007/S40259-015-0140-7
P577
2015-10-01T00:00:00Z